Keystone Symposia

Keystone Symposia Programming Consultants


The mission of Keystone Symposia's Study Group project is to gather experts in various disciplines to identify possible meeting topics and organizers for future Keystone Symposia meetings.

Through the support of these scientific professionals, we are able to strengthen our programs and develop new, forward-looking meetings to connect the scientific community for the benefit of society.

In addition to our Scientific Advisory Board, below are Study Group members who consulted on programming of our 2021 meeting series.


Galit Alter
MIT and Harvard University

Eduardo S. Arzt
University of Buenos Aires

Johan Auwerx
École Polytechnique Fédérale de Lausanne

Janelle S. Ayres
The Salk Institute for Biological Studies

Francis Barr
University of Oxford

Frederic Berger
Gregor Mendel Laboratory

Brian L. Black
University of California, San Francisco

James E. Bradner
Novartis Institutes for BioMedical Research

Amanda M. Brown
Johns Hopkins University School of Medicine

Scott P. Brown
Sunovion Pharmaceuticals

Anne Brunet
Stanford University

Bonnie Burgess-Beusse
National Institutes of Health

Roger Chammas
University of São Paulo

Navdeep S. Chandel
Northwestern University

Ines Chen
Springer Nature

Hongbo Chi
St. Jude Children's Research Hospital

Diana M. Cittelly
University of Colorado Anschutz Medical Campus

Andres Andres Contreras
Michigan State University

Aaron M. Cypess
NIDDK, National Institutes of Health

Jamaine S. Davis
Meharry Medical College

Vinicio de Jesus Perez
Stanford University

Christopher M. Evans
University of Colorado Denver - Anschutz Medical Campus

Rebecca Fitzgerald
University of Cambridge

Jude Fitzgibbon
QMUL

Paul S. Frenette
Albert Einstein College of Medicine

Wendy S. Garrett
Harvard School of Public Health

Daniel Gerlich
IMBA

Catherine Godson
University College Dublin

Trevor A. Graham
Queen Mary University of London

Frederick D. Gregory
U.S. Army Research Laboratory-ARO

Florian R. Greten
Institute for Tumor Biology and Experimental Therapy

Sergei Grivennikov
Fox Chase Cancer Center

Angela M. Gronenborn
University of Pittsburgh

Leonard P. Guarente
Massachusetts Institute of Technology

Albert J.R. Heck
Utrecht University

Jennifer R. Honda
National Jewish Health

Jackie Hunter
BenevolentBio

Wendy W. Hwang-Verslues
Academia Sinica

Mitsu Ikura
University of Toronto

Nicholas Jackson
Sanofi Pasteur

Steven E. Jacobsen
University of California, Los Angeles

Michael D.L. Johnson
University of Arizona - BIO5 Institute

Claus Jorgenson
CRUK Manchester Institute

Mikael C. I. Karlsson
Karolinska Institutet

Margaret Karow
Akrevia Therapeutics

Lloyd H. Kasper
Geisel School of Medicine at Dartmouth

George Kassiotis
Francis Crick Institute

Stavroula Kousteni
Columbia University

Amol Anant Kulkarni
Howard University

John M. Lambert

Christoph Lengauer
Third Rock Ventures

Jennie R. Lill
Genentech, Inc.

Daniel Lindén
AstraZeneca

Fu-Tong Liu
Academia Sinica

Jose M. Lora
enGene, Inc

Joaquin N. Lugo
Baylor University

Rodrigo Maillard
Georgetown University

Sascha Martens
University of Vienna

Paolo G. V. Martini
Moderna

Lynn A. Megeney
Ottawa Hospital Research Institute

Ira Mellman
Genentech, Inc.

Christian Metallo
University of California, San Diego

Kevin V. Morris
Center for Gene Therapy, City of Hope

Edward E. Morrisey
University of Pennsylvania

Dwain K. Morris-Irvin
StemVax Therapeutics

Kyungjae Myung
Institute for Basic Science

Peter D. Nagy
University of Kentucky

Mihai G. Netea
Radboud University

Lars Nitschke
University of Erlangen

Duncan Odom
University of Cambridge

Katrin Ottersbach
Erasmus Medical Center

Vito J. Palombella

Manolis Pasparakis
University of Cologne

Graham Pawelec
University of Tübingen

Josef M. Penninger
Institute of Molecular Biotechnology GmbH

Kornelia Polyak
Dana-Farber Cancer Institute, Harvard Medical School

Fulvio Reggiori
University Medical Centre Groningen

Robert C. Rickert
Pfizer Inc.

Frank Rigo
Ionis Pharmaceuticals

John L. Rinn
University of Colorado Boulder

Fatima Rivas
St. Jude Children's Research Hospital

Tim Robertson
Schrodinger Inc.

Louis A. Rosenthal
NIAID, National Institutes of Health

Carla V. Rothlin
Yale University

Andrew M. Scharenberg
Casebia Therapeutics

Orlando Schärer
IBS Center for Genomic Integrity

Sang-Uk Seo
Wide River Institute of Immunology, Seoul National University

Glenn E. Simmons, Jr.
University of Minnesota Medical School Duluth

Hongjun Song
University of Pennsylvania

Stephen Tait
Cancer Research UK Beatson Institute

Thomas Thum
Medical School Hannover

Leann M. Tilley
University of Melbourne

Kai-Michael Toellner
University of Birmingham

Victor L.J. Tybulewicz
Francis Crick Institute

Saba Valadkhan
Case Western Reserve University

Eva van Rooij
Hubrecht Institute

Marietjie Venter
University of Pretoria

Paul E. Verslues
Academia Sinica

Dario A. A. Vignali
University of Pittsburgh School of Medicine

Richard T. Wyatt
IAVI Neutralizing Antibody Center, The Scripps Research Institute

John R. Yates III
The Scripps Research Institute